NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $460,102 | -46.8% | 18,100 | -24.4% | 0.00% | -50.0% |
Q1 2023 | $864,924 | +25.4% | 23,926 | +37.4% | 0.01% | +33.3% |
Q4 2022 | $689,476 | -80.6% | 17,411 | -18.8% | 0.01% | -84.2% |
Q2 2021 | $3,556,000 | +612.6% | 21,449 | +329.8% | 0.04% | +22.6% |
Q1 2020 | $499,000 | +101.2% | 4,991 | +135.9% | 0.03% | +416.7% |
Q4 2019 | $248,000 | -28.7% | 2,116 | -65.3% | 0.01% | -60.0% |
Q3 2018 | $348,000 | -12.8% | 6,100 | +22.0% | 0.02% | -31.8% |
Q2 2018 | $399,000 | -77.0% | 5,000 | -75.0% | 0.02% | -83.1% |
Q1 2018 | $1,734,000 | -46.0% | 20,008 | -57.0% | 0.13% | -50.6% |
Q4 2017 | $3,214,000 | +892.0% | 46,555 | +1207.7% | 0.26% | +776.7% |
Q3 2017 | $324,000 | -79.2% | 3,560 | -83.0% | 0.03% | -81.2% |
Q2 2017 | $1,556,000 | -53.5% | 20,906 | -54.6% | 0.16% | -63.0% |
Q4 2016 | $3,345,000 | +1335.6% | 46,033 | +1966.1% | 0.43% | +982.5% |
Q3 2016 | $233,000 | -38.7% | 2,228 | -67.0% | 0.04% | -74.2% |
Q1 2016 | $380,000 | – | 6,742 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |